Max Chaffanet

10PUBLICATIONS
37CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSignal processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2023
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.

Sandra Udu-Ituma, José Adélaïde, Thi Khanh Le

|Aug 03, 2022
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.

Alexandre de Nonneville, Sébastien Salas, François Bertucci

|May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.

Mathias Neron, Arnaud Guille, Lucie Allegre

|May 14, 2022
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.

Emilien Billon, Gwenaelle Gravis, Arnaud Guille

|May 09, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate.

Olivier Cabaud, Ludovic Berger, Emerence Crompot

|Oct 29, 2021
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Chaïma Cherif, Dang Tan Nguyen, Clément Paris

Pageof 2

Frequent Collaborators

6 joint publications

Pascal Finetti

5 joint publications

François Bertucci

5 joint publications

Arnaud Guille

4 joint publications

Dimitri Churikov